We are live on ! Find out more
EAM

EFG Asset Management Portfolio holdings

AUM $773M
1-Year Est. Return 40.1%
This Fund
S&P 500
This Quarter Est. Return
+16.21%
1 Year Est. Return
+40.1%
3 Year Est. Return
+211.13%
5 Year Est. Return
10 Year Est. Return
AUM
$579M
AUM Growth
+$51.8M
Cap. Flow
-$7.99M
Cap. Flow %
-1.38%
Top 10 Hldgs %
19.57%
Holding
202
New
18
Increased
97
Reduced
75
Closed
12

Sector Composition

Rank Sector Weight
1 Healthcare 34.24%
2 Technology 24.7%
3 Consumer Discretionary 13.25%
4 Industrials 10.52%
5 Communication Services 8.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVDA icon
1
NVIDIA
NVDA
$5.08T
$16.1M 2.79%
178,830
-930
-0.5% -$67.4K
GOOGL icon
2
Alphabet (Google) Class A
GOOGL
$3.9T
$15.1M 2.6%
99,874
+23,926
+32% +$3.42M
AMZN icon
3
Amazon
AMZN
$2.52T
$13.4M 2.31%
74,184
+2,073
+3% +$346K
AAPL icon
4
Apple
AAPL
$4.71T
$13.1M 2.27%
76,573
-399
-0.5% -$72.5K
META icon
5
Meta Platforms (Facebook)
META
$1.54T
$10.7M 1.84%
21,992
-115
-0.5% -$51.3K
VEEV icon
6
Veeva Systems
VEEV
$29.4B
$10M 1.73%
43,172
-3,083
-7% -$665K
ISRG icon
7
Intuitive Surgical
ISRG
$119B
$9.72M 1.68%
24,372
+844
+4% +$319K
IDXX icon
8
Idexx Laboratories
IDXX
$42.4B
$9.49M 1.64%
17,576
-546
-3% -$298K
NTRA icon
9
Natera
NTRA
$37.8B
$8.76M 1.51%
95,784
-23,028
-19% -$1.73M
AVGO icon
10
Broadcom
AVGO
$1.86T
$6.99M 1.21%
52,800
-280
-0.5% -$34.7K
BMRN icon
11
BioMarin Pharmaceuticals
BMRN
$11.3B
$6.74M 1.16%
77,135
+7,519
+11% +$673K
SWAV
12
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$6.56M 1.13%
20,175
+901
+5% +$221K
V icon
13
Visa
V
$667B
$6.55M 1.13%
23,500
+2,823
+14% +$779K
COST icon
14
Costco
COST
$408B
$5.78M 1%
7,891
-1,103
-12% -$787K
CMG icon
15
Chipotle Mexican Grill
CMG
$40.9B
$5.71M 0.99%
98,250
-25,900
-21% -$1.32M
VCYT icon
16
Veracyte
VCYT
$4.62B
$5.69M 0.98%
257,388
+27,748
+12% +$677K
HALO icon
17
Halozyme
HALO
$9.44B
$5.69M 0.98%
140,089
+9,357
+7% +$351K
ALGN icon
18
Align Technology
ALGN
$11.9B
$5.65M 0.98%
17,241
+1,948
+13% +$572K
EXAS
19
DELISTED
Exact Sciences
EXAS
$5.51M 0.95%
79,833
+30,565
+62% +$1.93M
RARE icon
20
Ultragenyx Pharmaceutical
RARE
$2.71B
$5.45M 0.94%
116,836
+48,368
+71% +$2.28M
CRWD icon
21
CrowdStrike
CRWD
$187B
$5.34M 0.92%
66,704
-5,820
-8% -$445K
IQV icon
22
IQVIA
IQV
$34.1B
$5.2M 0.9%
20,565
+920
+5% +$215K
SYK icon
23
Stryker
SYK
$120B
$5.1M 0.88%
14,264
+638
+5% +$215K
NBIX icon
24
Neurocrine Biosciences
NBIX
$17.4B
$4.94M 0.85%
35,864
-637
-2% -$87K
NFLX icon
25
Netflix
NFLX
$286B
$4.87M 0.84%
80,260
-22,170
-22% -$1.25M

Similar funds

EFG Asset Management's Q1 2024 Portfolio in Review

As of Q1 2024, EFG Asset Management held 202 positions worth $579M, up 9.8% from $527M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

EFG Asset Management's Q1 2024 filing shows 18 new, 97 increased, 75 reduced and 12 closed positions. Its largest new stake was Carlisle Companies: 5,037 shares worth $1.97M. The largest sale was CRISPR Therapeutics, an estimated $4.68M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 34% a quarter earlier, followed by Technology and Consumer Discretionary.

  • EFG Asset Management's largest Q1 2024 buy was Carlisle Companies: 5,037 shares worth $1.97M.
  • EFG Asset Management added most to Alphabet (Google) Class A in Q1 2024, an estimated $3.42M increase.
  • EFG Asset Management's biggest Q1 2024 reduction was CRISPR Therapeutics, cutting an estimated $4.68M.
  • EFG Asset Management fully exited Workday in Q1 2024, selling an estimated $3.83M.
  • EFG Asset Management's ten largest holdings make up 20% of its $579M portfolio in Q1 2024.
  • EFG Asset Management opened 18 new positions and closed 12 in Q1 2024.
  • EFG Asset Management's portfolio value rose 9.8% quarter-over-quarter to $579M.

Based on EFG Asset Management's 13F filing for Q1 2024, filed 13 May 2024.